| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at … Type: | 2 | 0 | 0 | 478 |
 | ARTCLINE GmbH Innovative therapeutic procedures for Intensive Care Medicine for the treatment of severe infections ARTCLINE GmbH develops innovative therapy methods for intensive care medicine based on immune cells. Our current main project is the development of the so-called ARTICE technology for the treatment of bacterial sepsis. ARTCLINE's vision is the development of innovative immune cell-based therapy approaches and to make the technology available to physicians and hospitals worldwide. The safety and effectiveness of the therapy is our top priority. Our extensive cell biological, clinical and industrial experience in the fields of immunology, sepsis diagnostics and therapy help us to realize our … Type: | 0 | 0 | 0 | 13 |
 | Arterra Bioscience S.p.A. We care about everybody's health Arterra Bioscience is a biotech company listed on the “Euronext Growth Milan” market of Borsa Italiana since 2019, founded in Naples by M. Gabriella Colucci in 2004 with the aim of developing technologies and innovative solutions that find application in various industrial sectors. Arterra is a company strongly linked to the Campania region from which it derives the natural raw materials underlying many of its actives, as well as being able to take advantage of the ideas and enthusiasm of its young researchers. Biotechnology, R&D, Cosmetics, medical Device, Agriculture, and Agrifood Type: | 2 | 2 | 0 | 36 |
 | Arterya The experts in the detection of the artery Normandy start-up based in Caen, we develop Blood'Up, a medical device that allows the instant detection of arteries. Type: | 26 | 10 | 23 | 17 |
 |  ARTICA Therapeutics Development of covalent small molecules to transform the treatment of autoimmune and inflammatory disorders ARTICA Therapeutics and its seasoned team started operatons in 2020 and was supported by pre-Seed financing from BioGeneration Ventures. Artica is dedicated to developing novel small molecule medicines for inflammatory and autoimmune indicatons. Artca is at the forefront of covalent binding technology as well as in label-free cellular-based screening approaches. The unique combinaton of these capabilities allows rapid progression of the best drug candidates that have unprecedented and superior characteristics, creating novel and highly selective therapies for patients with unmet medical need. Type: | 1 | 0 | 0 | 13 |
 | Artios Taking control of the DNA Damage Response (DDR) Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) and repair pathways that are leveraged by cancer cells to promote their survival. Our specialized DcoDeR platform integrates Artios’ leadership capabilities, expertise and experience in DNA damage biology and drug discovery to systematically discover and develop medicines targeting the totality of the DDR. We have built an extensive DDR focused pipeline designed to address areas of high unmet needs across solid tumour indications including our ATR inhibitor, ART0380, and our Polθ inhibitor ART6043, as monotherapy and combination treatments. … Type: | 7 | 3 | 0 | 113 |
 | Artus Therapeutics Sealing The Broken Barrier Currently we are not hiring. Please beware of scammers Artus is a pre-clinical stage company developing first-in-class therapeutics for inflammatory and metabolic diseases by targeting barrier dysfunction. Type: | 1 | 1 | 0 | 3 |
 | Arvinas Leading the way in targeted protein degradation therapeutics Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC® protein degraders against validated and “undruggable” targets, the company has two clinical-stage programs: … Type: | 3 | 0 | 1 | 441 |
 | Arzeda The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules Arzeda, The Protein Design CompanyTM, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. Synthetic Biology, Bio-based Chemicals, and Protein Design Type: | 6 | 2 | 6 | 64 |
 | Ascend Advanced Therapies Ascend is a gene therapy development partner with a flexible platform featuring industry-leading analytics. Ascend is a development partner that supports life-science innovators in bringing gene therapy products to patients. Our team has deep expertise in gene therapy development and commercialization to offer unparalleled collaboration while working to develop your products from the bench through the clinic and beyond. Scientific innovation driven by quality and responsibility are at the core of our business. To set a new standard in the industry, we have invested in a world-class analytical toolkit within our flexible and scalable AAV platform of next-gen technologies, all … Type: | 2 | 0 | 2 | 114 |
 | ASCIL Biopharm We make injectable products better ASCIL Biopharm is a Drug Delivery Systems (DDS) company focused on research and development of formulations and medical devices with innovative solutions to enhance efficacy, safety and patient outcomes. Drug Delivery Systems, Parenteral, Biotechnology, Pharmaceuticals, and Medtech Type: | 0 | 0 | 0 | 25 |
 | Asdia [Automatic translation follows] The patient at the heart of our concerns The patient at the heart of our concerns ASDIA was created in Strasbourg in 2002 on the premises of the European Center for the Study of Diabetes (CEED), a research structure aimed at the development of innovative therapies, which could tomorrow relieve or even cure diabetes. This proximity has profoundly conditioned our professional approach, dedicated to supporting the patient in their daily life, while having an eye on their future. Building on this ongoing commitment to patient education and monitoring to ensure the effectiveness of their treatments, we have … Type: | 6 | 1 | 5 | 389 |
 | Aseptix Health Sciences N.V. Aseptix Health Sciences is a global leader in next generation antimicrobials, specializing in novel and patented infection prevention products and technologies for medical, professional and consumer use. Aseptix’ sustainable antimicrobial technologies enable products to safely, effectively and quickly kill contagious pathogens and are used in a wide range of applications, industries and therapeutic areas. The Company markets its products and technologies through a combination of Aseptix branded and third party branded products, and licenses on its portfolio of patented technologies to global industry leaders in their markets. The corporate mission is to become the global alternative for user unsafe and … Type: | 0 | 0 | 0 | 6 |
 | Aseptuva Aseptuva is a Swiss-UK Medtech startup, with offices in Bern, Zurich & Cambridge, working to prevent hospital infections We are developing a series of medical devices in the Class II (a,b) category, for in-situ disinfection of catheters and tubes inserted into patients inside an ICU environment, as well as on the outside. Our automated and targeted solution strives to prevent secondary infections in hospitals such as VAP, CLABSI etc, thereby reducing the burden on healthcare workers, and improving the overall patient experience by shortening hospital stay and saving additional costs. Type: | 4 | 1 | 3 | 6 |
 | Asgard Therapeutics Swedish biotech company exploring reprogramming as the next leap forward in cancer immunotherapy Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen presenting cells. Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard Therapeutics aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient. Cell Reprogramming, Cancer Immunotherapy, and … Type: | 1 | 0 | 1 | 21 |
 | Asklepios BioPharmaceutical, Inc. (AskBio) Pioneering science to create transformative molecular medicines. Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, Huntington’s disease, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10TM, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter … Type: | 5 | 2 | 1 | 467 |
 | ASKORN MEDICAL Experts in medical devices design & development, quality assurance and regulatory affairs. Design, development and manufacturing of medical devices, from class I to class III. Consulting on Quality Assurance and Regulatory Affairs ISO 13485 : 2016 certified company by French Notified Body GMED. Registered with the FDA. Affaires réglementaires, Conseil en qualité, and Conception de dispositifs médicaux classe I à III Type: | 1 | 0 | 1 | 6 |
 | Aspect Biosystems Developing bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases. bioprinting, tissue … Type: | 10 | 0 | 8 | 106 |
 | Aspivix Together, Re-imagining Gynecology with "Gentle" in Mind. Aspivix is a medical device company in women’s health, based in Switzerland, developing next-generation devices for gynecology. Our flagship product, CarevixTM, is the world’s first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology, including IUD insertion, hysteroscopy, cervical biopsies, fertility treatments, and more. CarevixTM is a medical device that has received in 2023 FDA-clearance for the US market, as well as the CE-Mark for the European countries. CarevixTM study published in the international journal, Contraception, in March 2023 demonstrated superiority over the use … Type: | 7 | 1 | 6 | 16 |
 | Assay Genie Creating World-Class Assays, Immunoassays, Antibodies & Proteins Assay Genie is a global life reagents company with over 120,000 products including immunoassays, antibodies, proteins & activity assays for research and development scientists. Founded in 2017, Assay Genie has offices in Dublin, Ireland & London, UK. With distributors in over 70 countries, Assay Genie works with scientists all around the World and counts Pfizer, J&J, Harvard University and many more of the World’s leading companies & universities among its customers. Company Achievements & Core Technologies Since its inception in 2017, Assay Genie has gone form strength-to-strength. The company began by building a … Type: | 0 | 0 | 0 | 14 |
 | Association Ville Hôpital Lutter contre la Douleur [Automatic translation follows] Contribute to improving the pathways of complex chronic pain patients Our objective is to intervene in support of primary care healthcare professionals caring for chronic pain patients in complex situations in the Ile de France region. The system offers information and training to healthcare professionals to harmonize practices and thus enable the decompartmentalization, coordination and continuity of care provided to chronic pain patients in complex situations. This network organization aims to improve the quality of care for patients suffering from chronic pain whatever its origin: pain resulting from cancer, headaches, chronic lower back pain, migraines, neuropathic pain, … Type: | 2 | 0 | 2 | 4 |
 | Astellas Gene Therapies Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina. Content is intended for a US audience. gene therapy and biotechnology Type: | 1 | 0 | 0 | 416 |
 | Astraveus We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. We build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies. biotech, medtech, cell therapy, gene therapy, CAR-T, MSC, iPS, ATMP, Tissue Engineering, cell based therapies, biotherapies, RMAT, and Manufacturing Tags: FrenchTech2030 Type: | 12 | 7 | 8 | 44 |
 | AstriVax Committed to address real-world challenges in vaccinology AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is building a first in class Plug & Play vaccine platform with a patented DNA based technology that launches self-amplifying live attenuated viruses. The versatile technology of AstriVax can be used to develop a wide range of vaccines to prevent and treat infectious diseases. AstriVax aims to address major challenges in vaccinology by developing novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad … Type: | 0 | 0 | 0 | 34 |
 | AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: | 2 | 0 | 1 | 11 |
 | ATANIS Biotech AG We revolutionize allergy diagnosis ATANIS Biotech AG has been incorporated as a spin-off company from the University of Bern by the four co-founders Mrs. Noemi Zbären, Prof. Thomas Kaufmann, Prof. Alexander Eggel and Prof. Jean-Pierre Kinet in Summer 2021. The company has developed a novel functional cell based assay that massively simplifies the diagnosis of allergies and can predict treatment success of therapies. This test will additionally be used to assess safety and efficacy of potential new drug candidates for allergy treatment as well as for the evaluation of allergenicity of various food products. The proprietary assay is offered through … Type: | 0 | 0 | 0 | 11 |
 | Athana® [Automatic translation follows] Hot flash relief with cryotherapy Athana® aims to create healthy health and well-being alternatives through a range of innovative products exploiting the therapeutic power of temperature. ❄️ Its first innovation is a connected cooling box that instantly relieves hot flashes by spreading refreshing sensations to the body's temperature-sensitive areas. Athana is supported by many players in the French tech ecosystem and has raised more than €100k to develop its unique portable cryotherapy technology. 🏆Grand Prize “innovating for healthy aging” - Malakoff Humanis. 🏆First Prize Regional Innovation Fund - Eurasanté. 🏆 Grand Prix Pépite national champion - Pépite … Type: | 8 | 3 | 6 | 6 |
 | ATLANTHERA Bone targeted delivery concept Atlanthera is a drug discovery company focused on bone diseases and bone cancer treatments Our vision: Be the leader in bone-targeted drug delivery to cure bone cancer and metastases Atlanthera can rely on a very high-qualified Team and a worldwide-known experts network Our concept: Bone-targeted delivery of anti-cancer drug www.atlanthera.com Watch our concept in video > https://youtu.be/m3BBWguO6hs Durg discovery, Bone-targeted drug delivery, Bone cancer, and Bone metastases Type: | 2 | 1 | 2 | 13 |
 | ATLANTIC BONE SCREEN Your partner for preclinical research in Oncology, Inflammation, musculoskeletal disorders and osteoarticular diseases Atlantic Bone Screen is a leading CRO (« Contract Research Organization ») specialized in high-quality preclinical evaluation services in the field of bone and joint diseases and more particularly in bone diseases from tumor origin. Thanks to its high expertise, Atlantic Bone Screen also evaluates biomaterials, either for orthopedic or dental applications. We provide high-quality services to support the characterization of drug candidates, nutraceuticals, biomaterials,... Located in Nantes, North-West of France and created in 2005 by Ronan LE BOT, CEO of the company, Atlantic Bone Screen puts … Type: | 3 | 1 | 3 | 25 |
 | Atomic AI Rational design of new molecules and medicines, enabled by the fusion of artificial intelligence and structural biology. Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research featured on the cover of Science (doi.org/10.1126/science.abe5650), provides new strategies to treat or cure previously-undruggable diseases by targeting RNA structure. We are an interdisciplinary team working across computational and experimental biology and believe that our strongest asset is our people. We're hiring! https://boards.greenhouse.io/atomai Type: | 2 | 0 | 1 | 35 |
 | Atomo Diagnostics Empowering Healthcare Consumers Atomo Diagnostics is a medical device manufacturer headquartered in Sydney, Australia with offices in South Africa and the United Kingdom. Atomo Diagnostics was established to capitalise on a core belief that healthcare products offering significantly improved levels of convenience, simplicity and user experience are disproportionately disruptive and have the potential to be very successful commercial market entrants. In 2013, Atomo introduced AtomoRapid, a range of safe, simple professional use tests that deliver fast and accurate results in both clinical and community settings. In 2014, AtomoRapid HIV won Best in Show at the Medical Device Excellence Awards (MDEA) … Type: | 0 | 0 | 0 | 27 |
 | Atoxigen ATOXIGEN is your partner in early R&D. We offer a variety of standardized or customized assays based on the latest innovations in the fields of cellular biology, molecular biology and genomics. Innovative predictive efficacy assays on reconstructed epidermis or primary cell lines from human explants (proteasome, autophagy, detoxification, anti-ageing...); in vitro genotoxicity testing (micronucleus and chromosome aberration tests); endocrine disruptor screening; customized services. Biotechnologies, Testing & Research, Evaluation toxicologique, and Assurance qualité Type: | 1 | 0 | 1 | 3 |
 | Atrandi Biosciences | Droplet Genomics Microfluidics, Single-Cell Analysis, & High-Throughput Screening Atrandi Biosciences is breaking new ground in high-throughput analysis technologies. Providing simple-to-adopt and easy-to-use droplet microfluidics and high-throughput screening (HTS) workflows. Droplet microfluidics technology is at the core of our products and provides an unmatched platform for exploring the complexity of biology in a high-throughput manner. Droplet microfluidics enables compartmentalizing molecular biology reactions into millions of pico-liter droplets, empowering you to study biological samples at the resolution of single cells and single molecules. Our work is at the intersection of life sciences, engineering, and machine learning. We deliver elegant solutions and novel tools for … Type: | 2 | 1 | 1 | 52 |
 | Auberle Auberle helps build strong individuals, families and communities. Auberle is a nationally recognized human services agency serving 4,000 children and families each year in 26 program areas in Southwestern Pennsylvania. Auberle was recognized by the Alliance for Children and Families as Agency of the Year in the country, primarily for our delivery of consistently high positive outcomes in programs across the agency; and for successfully launching 23 major initiatives last year that significantly improved services for the children and families we serve. The award and the accomplishments behind it demonstrate that leadership, pride and a focus on excellence are infused … Type: | 2 | 1 | 1 | 170 |
 | Augustinus Bader Revolutionary Science, Biological Wisdom. For every giant leap in technology, the human body remains our most remarkable machine: this belief has led Professor Augustinus Bader, one of the foremost scientists of his generation, to unlock the body's healing code. His breakthrough medical treatment activates and orchestrates the body's own stem cells to repair and regenerate. From skincare to clinical practice to biotech research, all our advances are grounded in a belief that the body is its own best therapist. Type: | 1 | 0 | 1 | 170 |
 | AUM Biosciences Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance biotech, oncology, drug development, Asian-biotech, Precision medicine, Digitalhealth, cancer, and small molecules Type: | 2 | 1 | 1 | 18 |
 | AURAL Alsace [Automatic translation follows] Progress 🚩and innovate🚀 Cooperate and commit to humanity HISTORICAL Created in 1972 by Professor JAHN, Head of the Nephrology and Hemodialysis Department at the Strasbourg University Hospital, AURAL is a non-profit association offering all treatment modalities for chronic kidney failure as well as hospitalization activity. at home and is present throughout the Alsace region. HAD's activity started in May 2004. In 1981 AURAL started Continuous Ambulatory Peritoneal Dialysis. The first assisted AD units were set up in 1985, and in 1996 they were the UMs. The DPA was created in 1994, and allows young patients to continue … Type: | 2 | 2 | 0 | 131 |
 | Aurealis Therapeutics Multi-target cell and gene therapies for unmet medical needs. Aurealis Therapeutics is a Swiss-Nordic Cell and Gene Therapy Platform Company. Our multi-target cell and gene therapy platform, based on genetically modified safe lactic acid bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers - deadly Cancers - Ovarian Cancer, Peritoneal Carcinomatosis - Inflammation. After successfully completing our Phase 1 clinical study in Diabetic Foot Ulcer (DFU) patients with our lead clinical product AUP-16, our DFU Phase 2 study is ongoing in Italy, Germany and Poland. Venous Ulcers and other ulcers will follow. In Oncology, … Type: | 1 | 0 | 1 | 18 |
 | Aureus Pharma Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes … Type: | 0 | 0 | 0 | 1 |
 | AuriGen Medical Delivering Hope to the Heart of our Patients AuriGen Medical are an NUI Galway medical device start up, developing the next generation in left atrial appendage implant technology for the treatment of medication resistant longstanding persistent atrial fibrillation. Type: | 1 | 1 | 0 | 15 |
 | Aurion Biotech We're on a mission to cure blindness with our transformational platform of advanced therapies Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care. Type: | 1 | 1 | 0 | 65 |
 | AUROBAC THERAPEUTICS Developing the next generation of precision medicines to fight antimicrobial resistance (AMR) and infectious diseases. AUROBAC THERAPEUTICS is a biopharmaceutical company created in 2022 by three highly renowned life sciences innovation companies, Boehringer Ingelheim, Evotec and bioMérieux, to develop the next generation of precision medicines addressing the medical needs associated with the development of antimicrobial resistance and infectious diseases. The company is building a pipeline of drug candidates for hospitalized patients, associated with rapid diagnostics to identify pathogens and their resistance mechanisms. This 40 million euros-funded joint-venture plans to cover the entire value chain of projects from R&D, including clinical … Type: | 3 | 1 | 2 | 16 |
 | Auto21 [Automatic translation follows] Cars and mobility of the 21st century Type: | 0 | 0 | 0 | N/A |
 | Autolus Therapeutics Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors. Type: | 0 | 0 | 0 | 520 |
 | Automated Engineering Services, Inc. Solutions for Better Biotech AES (Automated Engineering Services, Inc.) was formed after recognizing gaps with most system vendors and integrators who lack a strong background in Life Science, particularly with manufacturing operations in mind. In addition to services provided, AES also manufactures their own line of rockers, pump towers and 2-15L bioreactor systems. AES is made up of world class engineers and business experts from diverse backgrounds including operations, automation consulting, DCS/PLC programming, start-up, commissioning, validation and manufacturing. In addition to our professional engineering capabilities, AES has added a top-tier business development/sales-marketing team to the organization to continue to grow … Type: | 0 | 0 | 0 | 154 |
 | Avadel Pharmaceuticals plc Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead drug candidate, FT218, is an investigational formulation of sodium oxybate leveraging our proprietary drug delivery technology and designed to be taken once at bedtime for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. At Avadel, our core values foster an atmosphere of innovation and collaboration. In everything we do, we consider the patient experience, listening to their needs … Type: | 1 | 0 | 1 | 179 |
 | Avant Gratify Without Sacrifice: Technology for cleaner & more sustainable marine proteins Avant is the first cultivated fish company in Asia, with operations in Singapore and Hong Kong. Thanks to Avant's technology, we will be able to have fish meat without killing fish. Our cultivated fish products are more nutritious than conventionally produced fish, GMO-free, and pollutant-free. The pilot product focus of Avant's technology platform is fish and seafood tailored for the food culture of consumers in China and Asia. biotech, cultivated meat, and alternative protein Type: | 5 | 1 | 3 | 26 |
 | aVaxziPen aVaxziPen is focusing on next-generation vaccines for infectious diseases and emerging threat pathogens. Type: | 0 | 0 | 0 | N/A |
 | AventaMed Advancing ENT Surgery AventaMed is an emerging medical device company focused on simplifying surgical procedures and reducing costs for healthcare providers. AventaMed has developed a novel medical device which allows grommets to be placed safely and quickly in an office setting, eliminating the need for general anaesthetic and costly OR time. 7% of all children have grommets (2 million / year), making it a large market, worth over $5.4 billion worldwide. Type: | 1 | 1 | 0 | 9 |
 | AVEO Oncology Committed to delivering medicines that provide a better life for patients with cancer. AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the … Type: | 1 | 0 | 1 | 190 |
 |  AveXis, Inc. AveXis is now Novartis Gene Therapies Novartis Gene Therapies (formerly AveXis) is reimagining medicine to transform the lives of people living with rare genetic diseases. Utilizing cutting-edge technology, we are working to turn promising gene therapies into proven treatments, beginning with our transformative gene therapy for spinal muscular atrophy (SMA). Follow us on LinkedIn: https://www.linkedin.com/company/novartis-gene-therapies/ How to reach us: Novartis Gene Therapies 2275 Half Day Road, Suite 200 Bannockburn, IL 60015 Email: gtx.communications@novartis.com Office Phone: 847.572.8280 Toll-free Phone: 844.428.3947 Gene Therapy, Synthetic Biology, and Spinal Muscular Atrophy Type: | 1 | 0 | 0 | 107 |
 | AVNA AVNA (formerly OKAY Industries) is a contract manufacturing partner for leading medical device OEMs. We produce high-quality, complex components and sub-assemblies for precision powered, robotic, and mechanical medical and surgical devices. Our fully-integrated services and continual investment in advanced technology have positioned us as a market leader in metal forming, Multi-Axis CNC and Laser-Swiss machining, laser processing, plastic injection and over-molding, micro-machining, metal stamping, and automated assemblies. A wide variety of in-house manual, semi, and fully automated parts cleaning and finishing services combined with machine design, build, and automation technologies allow us to customize solutions that customers can rely on. … Type: | 0 | 0 | 0 | 266 |
 | AVROBIO Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring personalized gene therapy worldwide Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients’ own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato® gene therapy platform is scalable for planned global commercialization. … Type: | 3 | 1 | 0 | 40 |
 | AXELIFE [Automatic translation follows] Expertise - Prevention - Innovation Axelife is a 100% French Medtech, specialized in the field of assessment and prevention of cardiovascular risks. We design and develop assessment and prevention solutions, our first medical device: the pOpmeter, allows us to measure the Gold Standard pulse wave velocity for the measurement of arterial stiffness. The DM is class IIa and the company is ISO 13485. Our scientific team works on algorithms to calculate arterial age and has participated in the publication of more than 30 scientific publications which have supported the value of measuring arterial stiffness. Type: | 19 | 4 | 8 | 11 |
 | AXEME Récoltez le talent, cultivez l'innovation ! Founded in 2004, Axeme is a recruitment agency specialized in the field of Life Sciences, Medical Devices, In Vitro Diagnostics and Biotechnologies. We recruit specific profiles from the development of a product or solution to the marketing phase including highly scientific and technical profiles. Research and development, quality, regulatory affairs, clinical, field specialist, business, marketing profiles to c-level positions in France and worldwide. We share our knowledge and force with startups, medium-sized and major companies in medical device to structure their organization. Christine Horvais, the founder, has set up a European network of consultants … Type: | 10 | 1 | 4 | 12 |
 | AXIOS Senolytics [Automatic translation follows] Innovation for your health and well-being. Pharmaceutical company, R&D oriented dedicated to the development and marketing of senolytic compounds, food supplements and drugs against aging, age-related degenerative diseases and cancer. Type: | 1 | 1 | 0 | N/A |
 | Axol Bioscience Ltd. Better Human Disease Models World leaders in iPSC technology supporting the next generation of advanced models for drug discovery We provide biopharma and virtual organizations with human iPSC-derived cells and outsourced laboratory services to support drug discovery in the neurodegenerative, neuroinflammatory, and cardiotoxicity areas. As leaders in human induced pluripotent stem cell (iPSC) products and services, we support the pursuit of more human-relevant in vitro models to develop better, safer therapies. We have over a decade of experience supplying top ten Biopharma institutions and drug discovery companies with robust, high-quality in vitro models and custom lab services. Our industry-leading iPSC … Type: | 1 | 1 | 0 | 41 |
 | Axoltis Pharma The CNS Regeneration Company Axoltis pharma is a biopharmaceutical company dedicated to develop a first-in-class disease-modifying drug to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs. Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. Our products are first-in-class multifunctional peptides with high potential in many CNS disorders. neurodegenerative diseases, neurodegeneration, spinal cord injury, peptide, neuroprotection, neural repair, regeneration, drug, biotechnology, pharma, CNS, neurology, ALS, Parkinson, and Multiple Sclerosis Type: | 3 | 2 | 1 | 12 |
 | AXONIS Therapeutics AXONIS Therapeutics is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders AXONIS Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system. Operational since 2020, AXONIS is a seed-stage therapeutics company based in LabCentral, MA, and has assembled a team of world-leading innovators, serial entrepreneurs, successful drug developers, driven scientists and passionate patient advocates. Adult-onset central nervous system (CNS) disorders are an urgent, unmet, global and growing burden, especially as more people are living longer. Neuron degeneration … Type: | 4 | 0 | 3 | 14 |
 | AYOXXA Biosystems GmbH AYOXXA – the Translational Proteomics Company. Understanding complex biology from bench to bedside. AYOXXA - The translational proteomics company AYOXXA Biosystems GmbH, based in Cologne (Germany), is an international biotech company focused on the development of its proprietary beads-on-a-chip technology for advanced protein analysis. LUNARISTM. AYOXXA’s innovative multiplex protein analysis platform is a fully integrated system designed for the parallel analysis of multiple biomarkers in picogram amounts of biological samples, allowing scientists to gain a maximum of high quality and reproducible insights. LUNARISTM is fully scalable, with integrated, image-based quality control and transparent data processing and management, enabling translational proteomics … Type: | 0 | 0 | 0 | 23 |
 | AZELEAD An innovative drug discovery technology Good morning and welcome, we are pleased to introduce you to our structure. AZELEAD has developed ZebraScreen and ZebraTox, an innovative methodology for rapid and accurate assessment of the efficacy and toxicity of a drug In the past few years, we have seen a lot of attrition in the development of new drugs, with a failure rate of nearly 84% attributed to the low benefit of efficacy / toxicity. Three therapeutic areas are mainly affected by this decrease: oncology (failure rate of 29.5%), neurology (failure rate of 14%), and infectious diseases (failure … Type: | 0 | 0 | 0 | 5 |
 | Bactiguard AB Bactiguard is a global innovative medtech company with Swedish roots and a purpose to prevent infections. Bactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention technology and solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine. Bactiguard operates through license partnerships with leading global MedTech companies that apply … Type: | 0 | 0 | 0 | 98 |
 | Bactolife Empowering worldwide health through a fortified gut microbiome We are on a mission to enhance global gut health and support the fight against antimicrobial resistance. As a Danish biotech firm, we're pioneering the future of gut health with our unique ingredients, Binding Proteins. These breakthrough Binding Protein ingredients, natural and versatile enough for any food, beverage, or supplement, selectively bind and block harmful microbial activity without disturbing the beneficial microbiome—a truly revolutionary approach. Our products are specially formulated for diverse needs, benefiting everyone from mothers and children to the elderly, immune-compromised individuals, travelers, and even animals. Backed by investors such … Type: | 3 | 1 | 2 | 53 |
 | Balt We are Balt. Physician-inspired innovations. Patient-focused solutions. For more than 45 years, Balt has been leading the way – collaborating with physicians and institutions to develop elegant neurovascular solutions. As the premier global neurovascular platform, always seeking to expand beyond boundaries, we are now bringing our innovation to the peripheral vascular space. We introduced the first neurovascular intervention device in 1977. Now, we offer the world’s broadest portfolio of medical devices for ischemic and hemorrhagic stroke, as well as devices for peripheral embolization. In 2015, we embarked on an ambitious journey and more than quintupled our revenue and workforce, and … Type: | 3 | 3 | 1 | 404 |
 | BANCO FARMACEUTICO - Fondazione ETS [Automatic translation follows] So that no one has to choose whether to eat or heal themselves anymore Since 2000, the Banco Farmaceutico ETS Foundation has been collecting and recovering medicines (approximately 1.5 million per year - both over-the-counter and with a prescription) to be donated to over 1,700 welfare organizations that offer free social and health assistance to the poor. It does this mainly through 3 activities: DRUG COLLECTION DAY On the second Saturday of February each year, more than 18,000 volunteers in more than 4,500 pharmacies participating in the initiative invite customers to donate one or more medicines for … Type: | 6 | 0 | 6 | 18 |
 | Banook Group People serving Science, Science serving people Since 1999, Banook Group is one of the few established international providers of cardiac safety services, central imaging, endpoint adjudication, eCOA/ePRO and Virtual Clinical Trials. From early to late stage, generation and management, provisioning to scientific analysis, Banook Group and its medical expertise has become a key player for clinical trials. To learn more, please visit our website www.banookgroup.com Cardiac Safety, Endpoint Adjudication, Central Imaging, eCOA/ePRO, Virtual Clinical Trials, Clinical Project Management, Clinical Trial Provisioning, and Clinical Trial Support Type: | 3 | 1 | 2 | 44 |
 | BariaTek BariaTek is a clinical stage company dedicated to treating obesity via a reversible non-invasive endoscopic approach. BariaTek Medical is a clinical stage company dedicated to addressing obesity via minimally invasive endoscopic approaches. Obesity is one of the most debilitating pandemics affecting humanity: More than 2 billion people are overweight of which 1 billion suffer from obesity. People suffering from obesity tend to lead shorter, less healthy, lives. Treating overweight-related conditions (diabetes, hypertension, sleep apnea and others) is projected to cost G-20 nations on average 8.7% of their health budgets over the next three decades which is estimated by the United … Type: | 1 | 0 | 1 | 14 |
 | Barinthus Biotherapeutics Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates. Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics. With a broad pipeline, built around four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI; Barinthus Biotherapeutics is advancing a pipeline of five product candidates across a diverse range of therapeutic areas, including: VTP-300, an immunotherapeutic candidate designed as a potential component of … Type: | 8 | 2 | 4 | 139 |
 | Basecamp Research We leverage our unprecedented knowledge of the natural world to create better medicines, better food and better products Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. We match and refine novel proteins for our partners' exact industrial, therapeutic or diagnostic applications using BaseGraphTM, a new generation of AI design that is powered by the first-ever high-resolution map of global genetic biodiversity. Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need for expensive and time-consuming directed evolution campaigns. We're … Type: | 9 | 0 | 8 | 34 |
 | BASF Pharma Solutions Inspiring Medicines for better Lives BASF Pharma Solutions produces innovative excipients and active ingredients of outstanding quality and performance. With a global team of industry experts and digital solutions, BASF supports its customers in developing efficient, cost-effective and reliable formulations. Equipped with an in-depth understanding of multiple technologies and applications, we have the knowledge and resources to make pharmaceutical drug delivery and the manufacturing of drugs and biologics safer and more sustainable. We create solutions for Biopharma, Parenteral, Oral, Solubilization and Topical applications and are also a leading supplier of selected APIs such as ibuprofen, L-menthol and Omega-3. About BASF … Type: | 1 | 0 | 1 | 0 |
 | Basilea Pharmaceutica For the benefit of patients Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in the heart of the life sciences hub of Basel area, Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands: Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. In addition, we have several preclinical anti-infective assets in our portfolio. Basilea currently has about 150 employees and is listed on the SIX Swiss Exchange (SIX: … Type: | 1 | 1 | 0 | 203 |
 | Bastion Therapeutics Creating a future where inflammatory disorders are curable Bastion Therapeutics is a preclinical stage biotechnology company with a mission to develop novel Treg therapies to address the unmet clinical need for inflammatory disorders. We leverage our proprietary GRITTM platform technology to enhance Tregs to modulate the immune system and overcome challenges associated with previous generations of Treg therapies. Our vision is to provide life-changing therapies that are efficacious, durable and safe to patients suffering from inflammatory disorders. Type: | 5 | 0 | 5 | 10 |
 | Batavia Biosciences Accelerate Biotechnology Batavia Biosciences is a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies. We are not your standard CDMO - our customers regularly refer to us as their product development partner and thought partner. We focus on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization to clinical manufacturing. Headquartered in Leiden, The Netherlands, Batavia Biosciences is privileged to have strong strategic partners in … Type: | 0 | 0 | 0 | 212 |
 | Bavarian Nordic For us, it is all about improving and saving lives Improving and saving lives through innovative vaccines is at the heart of what we do in Bavarian Nordic, and we have more than 25 years of experience in developing life-saving vaccines. We are a fully integrated vaccine company focused on the development, manufacturing and commercialization of our vaccines, and our vision is to become one of the largest pure play vaccine companies in the world. We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance the … Type: | 2 | 1 | 2 | 1,311 |
 | Bcell Design Best-in-class monoclonal antibodies with Human Fc Based in Illkirch-Graffenstaden (France), Bcell Design is a monoclonal design expert. The company has developed unique technologies to produce human Fc monoclonal antibodies with excellent reactivity. 1/ IVD Our high-quality monoclonal antibodies are specifically designed for in vitro diagnostics. They are used for positive controls, calibrators and quality controls. Some products have been tested and found reactive in DiaSorin LIAISON XL assays, BioMérieux Vidas, bioVendor KleeYa system etc... Our products are included in manual and automatic kits, under IVDR and FDA regulations. They are used as a quality control tool for all types of … Type: | 3 | 2 | 3 | 6 |
 | BDD A World Class Drug Delivery Company BDD combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products. Rapid parallel clinical testing with BDD SWIFT significantly reduces the time from product concept to clinical success. Recognizing that one size does not fit all we specialise in providing responsive, flexible and innovative solutions to our customers. Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time. Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority … Type: | 0 | 0 | 0 | 44 |
 | Béa Fertility Startup building the first clinical grade fertility treatment | Increasing access to effective and affordable treatments The future of fertility care is here. Affordable, at-home ICI-based fertility treatment designed to help you get you pregnant. Fertility and Medical Device Type: | 3 | 0 | 2 | 23 |
 | Beanfields The Positively Addicting Bold Bean Chip. Beanfields is on a mission to inspire the world to upgrade their snacking habits with crunchy, mouth-watering BEAN-BASED chips that are POSITIVELY ADDICTING and deeply nutritious. Every bag of Beanfields chips is full on flavor, packed with protein and fiber, Non-GMO, gluten free, and vegan. Finally, an addiction you can feel good about. Beanfields are currently sold throughout all 50 states, Canada, and other countries. We have a unique social impact partnership with Homeboy Industries, the largest and preeminent gang rehabilitation and re-entry program in the world. Bean and Rice Chips, Gluten-Free Snacks, Vegan … Type: | 2 | 0 | 1 | 5 |
 | Beckley Psytech Transforming psychedelics into effective and licensed medicines for neuropsychiatric conditions. Beckley Psytech is a private, clinical-stage biotechnology company dedicated to improving the lives of people suffering from neuropsychiatric disorders by transforming psychedelics into effective and licensed medicines. Our vision is for clinically validated psychedelic medicines to be integrated into modern medical practice in order to help patients living with depression and other profoundly debilitating neuropsychiatric conditions with a high unmet need. Founded in 2019, and underpinned by more than two decades of pioneering scientific research from the Beckley Foundation, we combine world-leading psychedelic science with deep neuropsychiatric drug development expertise … Type: | 3 | 0 | 3 | 61 |
 | Beckman Coulter Life Sciences (formerly Labcyte Inc.) Echo liquid handlers and Access workstations are now Beckman Coulter Life Sciences products. Labcyte is now Beckman Coulter Life Sciences! Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality … Type: | 4 | 1 | 3 | 54 |
 |  Belyntic GmbH The Precision Vaccines Company Belyntic creates novel vaccines for viral diseases with unmet medical need. We have developed and validated a new platform technology, that generates self-adjuvant synthetic long peptides for a safe and durable induction of cellular immunity. Drug development, Cellular immunity, and Platform technology Type: | 1 | 0 | 0 | 2 |
 | BePharBel Manufacturing SA HELPING CREATE A HEALTHIER WORLD THROUGH EXCELLENCE As CDMO (Contract and Development Manufacturing Organization), BePharBel Manufacturing contributes to improve the health of all by supplying our pharma partners: - a genuine end-to-end development and manufacturing solution - that facilitates and accelerates drugs availability for patients. Our main activities are: 1) CDMO BePharBel Manufacturing provides an integrated end-to-end solution for the development and manufacturing, under European GMP conditions, of drugs (small molecules and antibiotics) and medical devices. Our expertise field is the development of new formulations and drug formulations over more than 10 different sterile and non-sterile galenic forms (injectables, powder … Type: | 0 | 0 | 0 | 89 |
 | Berkeley Lights Accelerate your path to live cell function and recovery Berkeley Lights is a leading functional cell biology company focused on enabling and accelerating the rapid development and commercialization of bio-therapeutics and other cell-based products for our customers. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Our platform is a fully integrated, end-to-end solution, comprising proprietary consumables, including our OptoSelectTM chips and reagent kits, advanced automation systems, and application software. We developed the Berkeley Lights … Type: | 7 | 1 | 5 | 56 |
 | BetaGlue Technologies Localized Internal β-emitting Radiotherapy BetaGlue Technologies is a clinical stage oncology company that has developed an advanced radiotherapy platform enabling localised targeted treatment of both unresectable solid tumours and also treatment of surgical resection margins called "BAT-90". radiotherapy, nuclear medicine, oncology, and medical devices Type: | 0 | 0 | 0 | 14 |
 | Beta Innov [Automatic translation follows] Development of innovative drugs with curative potential in Immunology and Cancerology. Beta Innov SAS is an innovative pharmaceutical Research and Development company, created in March 2009 by patient families. Beta Innov aims to achieve a major therapeutic leap in the treatment of autoimmune diseases and Glioblastoma by using a physiological (Immunology) or metabolic (Glioblastoma) approach avoiding the costs of gene therapies and the adverse effects of therapies. by antibodies. Type: | 0 | 0 | 0 | 14 |
 | BGene Genetics Believe in Nature, belong to Future BGene aims at developing sustainable and resilient production ways for high value added, biobased molecules. To this end, BGene develops expertise in domains such as molecular biology, microbiology, biochemistry, process engineering and computer sciences. Food and feed, pharma, cosmetics, chemistry, and environment are among the diverse markets that BGene can address thanks to the cutting-edge bioprocesses developed by BGene know-how. Strain engineering, Microorganism chromosome engineering, Synthetic Biology, Molecular Biology, Bioinformatics, and Bioprocess Type: | 7 | 6 | 2 | 23 |
 | Bicoll We envision molecules for epilepsy and longevity: Research and development of novel patentable structures. Bicoll is an expert in bioactive plant-derived small molecules with outstanding expertise in high-tech natural product chemistry and validated experience in medicinal chemistry. Currently Bicoll focuses on two main fields such as neurodegenerative disorders (primarily, epilepsy) and longevity. In both of the fields it develops own preclinical candidates. Drug Discovery Services, Custom Synthesis, Medicinal Chemistry Services, Natural Product, Plant-based compounds, Food supplements, Nutraceuticals, and Cosmetics Type: | 2 | 0 | 0 | 14 |
 | Bicycle Therapeutics Bicycle Precision Guided Therapeutics. Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycles attractive candidates for drug development. Bicycle is evaluating BT5528, a second-generation Bicycle Toxin Conjugate (BTCTM) targeting EphA2; BT8009, a second-generation BTC targeting Nectin-4, a well-validated tumor antigen; and BT7480, a Bicycle TICATM targeting Nectin-4 and agonizing CD137, … Type: | 6 | 2 | 1 | 272 |
 | BigHat Biosciences BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids … Type: | 11 | 0 | 11 | 91 |
 | BILHI Genetics The genetic platform to EXPLORE, PREDICT and CURE fibrotic diseases We are a team of GENOMIC EXPLORERS dedicated to cure fibrosis. We work hand in hand with populations under strong natural selection pressure (e.g. Amerindians from Brazil, Allurs, Bantous from Uganda, Hans from Wuhan...) to identify GENETIC VARIANTS of susceptibility or resistance to fibrotic diseases. To explore the mechanisms of fibrosis in new depth, we rely on a unique genomic strategy based on medical genetic expertise in fibrosis, local networks of fields experts and state-of-the-art AI. In cooperation with local institutions & KOLs, our experts have analyzed tens of thousands … Type: | 1 | 1 | 1 | 7 |
 | BINDER GmbH Best conditions for your success --- BINDER - Best conditions for your success The world's largest specialist in simulation chambers for the scientific and industrial laboratory. Whether cold testing, heat testing, stress testing, stability testing or drying paint, when developing our products we have but one goal: to provide the perfect solution for exactly your area of application in the scientific and industrial laboratory. Clients include: Bayer, BASF, Novartis, Aventis, Schering Plough, Max Planck Institute, Bayer Pharma, Byk Gulden, Boehringer Ingelheim, DKFZ, Daimler, Bosch, Siemens, Toyota, Philip Morris, Kraft Food, Nestlé and many more! Microbiological Incubators and Heating Ovens for … Type: | 1 | 0 | 0 | 229 |
 | BioAge Labs We are harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. BioAge is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Our proprietary platform, which encompasses >65M molecular measurements spanning 45+ years of human aging, unlocks a universe of novel biological insights and druggable mechanisms for age-related disease. The company’s lead program, azelaprag, is a potential first-in-class oral APJ agonist entering Phase 2 trials in combination with tirzepatide for the treatment of obesity in older adults. Azelaprag has the potential as … Type: | 2 | 1 | 1 | 83 |
 | BioAxial, part of Telight Explore the Unseen BioAxial is now part of Telight. Please follow our news at Telight LinkedIn page https://linkedin.com/company/telight TELIGHT specializes in a field of instruments employing light optics, in particular, providing innovative types and solutions for light microscopy. Super Resolution Microscopy, Fluorescence Microscopy, Conical Diffraction Optical Components, Nanoscopy, Living Cell Imaging, Low phototoxicity, Standard Workflow, Multicolor Imaging, and Intuitive Type: | 1 | 1 | 0 | 9 |
 | BioC3 Synthetic Biology BioC3 is a French biotech startup that has created an innovative biocatalysis platform. This brings standardized and highly efficient reaction cascades thanks to stabilized enzymes. The reactions take place in water at ambient temperature and atmospheric pressure, using carbon sources that are renewable. No polluting by-product is generated. Type: | 0 | 0 | 0 | 5 |
 | BioCardia, Inc. a leader in the development of comprehensive solutions for cardiovascular regenerative therapies We are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. BioCardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its CardiAMPTM and CardiALLOTM therapies. Clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with intramyocardial delivery of marrow-derived cells. These programs are enabled by the Company's HelixTM transendocardial delivery systems and Morph® vascular access products, which are partnered to enable other promising biotherapeutic programs. Type: | 1 | 1 | 0 | 27 |
 | Bioceltix Bioceltix is changing the veterinary therapy standards. We develop innovative biopharmaceuticals based on stem cells. Bioceltix is a biotech start-up which deals with the development of stem cell-based medicinal products for veterinary use. Currently, our main goal is to implement a biopharmaceuticals based on allogenic stem cells. The medicines will be primarily to serve the treatment of accompanying animals. The new product candidates will become a milestone in the field of stem cell-based biopharmaceuticals for veterinary use. As one of the first such Europe-based company, Bioceltix product intends to go through the full registration path to a marketed drugs devised … Type: | 0 | 0 | 0 | 27 |
 | BioCentriq Manufacturing Partner for Cell and Gene Therapy Process Development and Clinical Production BioCentriq is an established, highly collaborative, global cell therapy CDMO. The company has been successfully manufacturing drug products for use in human clinical trials since 2022. In June of 2023, BioCentriq launched its LEAPTM Advanced Therapy Platform which helps cell therapy developers move from contract to clinic in as short as six months. With industry recognized scientists, engineers, analysts, and manufacturing specialists, established quality systems and modern infrastructure, BioCentriq is a proven strategic partner for the development and manufacturing of both autologous and allogeneic cell therapy products. The … Type: | 1 | 0 | 1 | 80 |
 | BioCryst Pharmaceuticals, Inc. We develop oral small-molecule and protein therapeutics to target complement-mediated and other rare diseases. BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with complement-mediated and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. We are a commercial-stage biotech company with US headquarters in Durham, North Carolina. Our European headquarters is in Dublin, Ireland, and our Discovery Center of Excellence is rooted in Birmingham, Alabama, with many other regional offices around the world. As … Type: | 0 | 0 | 0 | 561 |
 | BioCytex BioCytex is a contract research organization specializing in biomarker detection and analysis of normal and pathological cells in whole blood, bone marrow and other tissue samples. With over 20 years of experience in flow cytometry, we have a wide range of experience in developing and validating assays to suit many different requirements including immunophenotyping, detection of intracellular / extracellular markers, antigen binding assays. With the capacity to simultaneously measure multiple parameters on hundreds of individual cells per second, flow cytometry is a powerful technology with a wide variety of applications in pharmaceutical development. BioCytex is working with worldwide pharmaceutical companies. … Type: | 0 | 0 | 0 | 23 |
 | Biodesix, Inc. Leader in Diagnostic Solutions, providing Testing & Biopharma Services A leading diagnostic solutions company with five Medicare-covered tests for the lung cancer (oncology) healthcare continuum. Partnering with BioPharma companies with our unique portfolio of patented technologies, science, and processes. #proteomics #genomics #liquidbiopsy #bdsx #biodesix #lungcancer #biopharma #biotech #lifesciences Molecular Diagnostics, Predictive, Prognostic and Mutation Tests, Companion Diagnostics, Mass Spectrometry Analysis of Biological Samples, oncology, lung cancer, lung disease, cancer diagnostics, biomarkers, liquid biopsy, ddPCR, Non-Small Cell Lung Cancer, Lung Nodules, Nodule Management, Proteomics, Artificial Intelligence, Genomic Testing, Clinical Trials, Biopharma Services, genomics, and multi-omics Type: | 2 | 0 | 2 | 241 |
SMB